Title

Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome

Document Type

Journal Article

Publication Date

7-1-2019

Journal

Annals of Thoracic Surgery

Volume

108

Issue

1

DOI

10.1016/j.athoracsur.2018.11.047

Abstract

© 2019 The Society of Thoracic Surgeons Angiotensin II is a novel vasopressor recently approved for the treatment of vasodilatory shock. We describe a case in which Angiotensin II was used to treat post–cardiopulmonary bypass vasoplegic syndrome in a patient who was refractory to standard vasopressors and other rescue therapies. Despite requiring high-dose vasopressors, the patient was extubated within 24 hours and has met key quality metrics defined by The Society of Thoracic Surgeons.

Share

COinS